PEN-866 in Patients With Advanced Solid Malignancies

Conditions:   Carcinoma;   Sarcoma;   Rhabdomyosarcoma;   Neoplasms;   Small Cell Lung Cancer;   Triple Negative Breast Cancer;   Adenocarcinoma of the Pancreas;   Colorectal Carcinoma;   Gastric Adenocarcinoma;   Advanced Cancer;   Solid Tumor;   Solid Carcinoma Intervention:   Drug: PEN-866 Sponsor:   Tarveda Therapeutics Recruiting - verified July 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials